REQUEST A DEMO
Total
USD $0.00
Search more companies

Fabian Giovanni Urrego Linares (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Fabian Giovanni Urrego Linares Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fabian Giovanni Urrego Linares is based in Colombia. The head office is in Bogota D.C.. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on March 30, 2017. 12 (2024) employees currently work for Fabian Giovanni Urrego Linares. In its most recent financial highlights, the company reported a net sales revenue increase of 9.55% in 2023. Its’ total assets recorded a growth of 404.87%.

Headquarters
Av El Dorado 69 C 03 Lc 111
Bogota D.C.; Bogota D.C; Postal Code: 0615

Contact Details: Purchase the Fabian Giovanni Urrego Linares report to view the information.

Basic Information
Total Employees:
Purchase the Fabian Giovanni Urrego Linares report to view the information.
Outstanding Shares:
Purchase the Fabian Giovanni Urrego Linares report to view the information.
Incorporation Date:
March 30, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fabian Giovanni Urrego Linares report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
9.55%
Total operating revenue
9.55%
Operating profit (EBIT)
-48.01%
Total assets
404.87%
Total equity
3884.81%
Operating Profit Margin (ROS)
-5.49%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?